Carvedilol PAH A Pilot Study of Efficacy and Safety
Status:
Terminated
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
Estimate the effect of chronic beta-adrenergic receptor blockade with carvedilol on RV
function in patients with PAH.
Assess the safety and tolerability of chronic carvedilol therapy in patients with PAH
Phase:
Phase 1
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute